Microchip Technology (MCHP) — Earnings Preview

Company

Microchip Technology Incorporated

Ticker

MCHP (NASDAQ)

Reporting Period

1Q FY2027 (Quarter ending June 30, 2026)

Earnings Date

August 6, 2026 (After Market Close)

Prepared

August 5, 2026

Sector ETF Benchmark

iShares Semiconductor ETF (SOXX)

1. Earnings Preview

Key Takeaway: Setup is constructive — consensus is a manageable bar after the strong Q4 FY2026 beat, and the single biggest swing factor is whether PCIe Gen 6 production ramp and data center momentum can offset any softness in legacy end markets and validate the accelerating revenue trajectory management has signaled.

Heading into the 1Q FY2027 print, MCHP's setup is the most constructive it has been in several years. The company guided June-quarter revenue up ~11% sequentially (plus or minus 1%), representing ~35% year-over-year growth, with non-GAAP EPS guided to $0.67–$0.71 — a bar that consensus has largely converged to ($0.70 current estimate). The key question is not whether MCHP beats the quarter, but whether management can sustain the narrative of innovation-driven growth replacing inventory-depletion-driven growth — specifically, whether PCIe Gen 6 production ramp (8 design wins, one worth >$100M/year in production) and data center solutions growth toward $500M in calendar 2026 are on track. Estimate revisions have moved sharply higher since the May 7 earnings beat (1Q FY2027 EPS consensus up from $0.38 to $0.70), suggesting the Street has already re-rated the story, which raises the bar for a positive surprise. The stock has given back roughly 23% from its post-earnings peak (~$103) to ~$80 as of August 4, underperforming SOXX over the same window, creating a more attractive entry but also reflecting investor skepticism about the pace of the PCIe ramp and the COO departure announced July 23. The wildcard is supply constraint breadth: management warned that lead times are extending broadly across 70–80% of foundry nodes and substrates are tight — if this is translating into delinquencies or customer frustration rather than pricing power, it could cloud the otherwise positive demand narrative.

2. KPIs & Consensus Expectations

Key Takeaway: Consensus is a manageable but not low bar — EPS of $0.70 sits near the top of guidance ($0.67–$0.71), leaving limited room for upside surprise on the bottom line. Revenue at $1.457B is the bigger swing factor: any upside driven by PCIe Gen 6 initial shipments or stronger-than-expected distribution restocking would be the key positive catalyst.

Table 1 — Current Quarter Snapshot (1Q FY2027, Quarter Ending June 30, 2026)

KPI

Last Quarter Actual (4Q FY2026, Mar-26)

Prior Year Period (1Q FY2026, Jun-25)

Consensus Estimate (1Q FY2027)

YoY Change

Guidance (May 7, 2026)

Consensus vs. Guidance Midpoint

Revenue (Sales)

$1,311M

$1,140M

$1,457M

+27.8% YoY

Up ~11% seq. (±1%); ~$1,455M midpoint

+0.1%

Non-GAAP EPS (Diluted - Operating)

$0.57

$0.35

$0.70

+100% YoY

$0.67–$0.71 ($0.69 midpoint)

+1.4%

Non-GAAP Gross Profit

$808M (61.6%)

$646M (56.6%)

$916M (~62.9%)

+41.8% YoY

62.25%–63.25% (62.75% midpoint)

+0.2pp vs. midpoint

Non-GAAP Operating Income

$401M (30.6%)

$277M (24.3%)

$494M (~33.9%)

+78.3% YoY

33.0%–34.5% (33.75% midpoint)

+0.2pp vs. midpoint

Non-GAAP Operating Expenses (% of Sales)

31.0%

32.3%

~29.0%

-330bps YoY

28.75%–29.25% (29.0% midpoint)

At midpoint

Sources: Visible Alpha Consensus and Actuals Data (Sales, EPS – Diluted – Operating, Gross profit/(loss) – Operating, Operating income/(loss) – Operating). Guidance from MCHP Q4 FY2026 Earnings Call, May 7, 2026. Note: Segment revenue KPIs (Automotive, Industrial incl. A&D, Data Center) not available in Visible Alpha for this ticker.

Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs: Revenue & Non-GAAP EPS)

Quarter

KPI

Reported

Consensus Est.

Surprise %

Result

4Q FY2026 (Mar-26)

Revenue

$1,311M

$1,263M

+3.8%

Beat

4Q FY2026 (Mar-26)

Non-GAAP EPS

$0.57

$0.51

+11.8%

Beat

3Q FY2026 (Dec-25)

Revenue

$1,186M

$1,185M

+0.1%

In-Line

3Q FY2026 (Dec-25)

Non-GAAP EPS

$0.44

$0.42

+4.8%

Beat

2Q FY2026 (Sep-25)

Revenue

$1,140M

$1,137M

+0.3%

In-Line

2Q FY2026 (Sep-25)

Non-GAAP EPS

$0.35

$0.34

+2.9%

Beat

1Q FY2026 (Jun-25)

Revenue

$1,076M

$1,056M

+1.9%

Beat

1Q FY2026 (Jun-25)

Non-GAAP EPS

$0.27

$0.24

+12.5%

Beat

4Q FY2025 (Mar-25)

Revenue

$971M

$963M

+0.8%

In-Line

4Q FY2025 (Mar-25)

Non-GAAP EPS

$0.11

$0.11

0.0%

In-Line

3Q FY2025 (Dec-24)

Revenue

$1,026M

$1,068M

-3.9%

Miss

3Q FY2025 (Dec-24)

Non-GAAP EPS

$0.20

$0.28

-28.6%

Miss

2Q FY2025 (Sep-24)

Revenue

$1,164M

$1,153M

+1.0%

In-Line

2Q FY2025 (Sep-24)

Non-GAAP EPS

$0.46

$0.44

+4.5%

Beat

Pattern: MCHP has beaten or matched revenue consensus in 7 of the last 8 quarters, with the sole miss in 3Q FY2025 (Dec-24) driven by the depth of the inventory correction. EPS beats have been consistent since the trough, with the magnitude of beats accelerating as the recovery has taken hold — a pattern that sets a higher implicit bar for the current quarter. Source: Visible Alpha Consensus and Actuals Data.

3. Guidance & Commentary Evolution

Key Takeaway: Guidance has been unchanged since the May 7 earnings call — no formal revision has been issued. However, management's tone has shifted more constructive at subsequent conferences, with the BofA conference (June 2) confirming gross margin guidance at 62.75% and the JPMorgan conference (May 20) reaffirming bookings momentum continuing into May. The pricing strategy shift announced June 1–2 (price increases effective September) is the most material post-earnings development but does not affect June-quarter guidance.

Metric

Initial Guidance (May 7, 2026 Earnings Call)

Revised Guidance

Current Consensus

Note

Revenue (1Q FY2027)

Up ~11% seq. (±1%); ~$1,455M midpoint

$1,457M

Unchanged. JPMorgan conf. (May 20) reaffirmed 11% seq. growth. Bookings momentum continued into May.

Non-GAAP Gross Margin

62.25%–63.25%

~62.9%

BofA conf. (June 2) confirmed 62.75% midpoint. Underutilization charges expected to decline from $46.6M in 4Q FY2026.

Non-GAAP Operating Expenses (% of Sales)

28.75%–29.25%

~29.0%

Unchanged. ~$15M QoQ increase at midpoint driven by bonus programs and compensation restoration.

Non-GAAP Operating Profit (% of Sales)

33.0%–34.5%

~33.9%

Unchanged. Trending toward long-term 40% target.

Non-GAAP EPS (Diluted)

$0.67–$0.71

$0.70

Unchanged. Consensus at top of range; non-GAAP tax rate for FY2027 guided ~10%.

Net Debt / Adj. EBITDA

Expected to drop below 3.0x

N/A — not in VA

Confirmed at JPMorgan conf. (May 20) and BofA conf. (June 2). Key deleveraging milestone.

Pricing Strategy (Post-Earnings Development)

No price increases planned (as of May 7)

↑ Price increases announced June 1–2, 2026

N/A

↑ New development: Cost pass-through price increases effective ~September; primary P&L impact in Dec-26 quarter. June guidance unaffected (confirmed at Mizuho conf., June 9).

4. Guidance vs. Estimate Revision Tracker

Key Takeaway: Estimates have moved sharply higher since the May 7 beat — 1Q FY2027 EPS consensus jumped from $0.38 to $0.70 (+84%), and FY2027 EPS from $3.16 to $3.21 (+1.5%). Estimates are tracking at or slightly above guidance midpoints, meaning the bar is now set at the top of the guided range. The gap between current consensus and guidance midpoint is thin, leaving limited cushion for a miss.

KPI (Period)

Estimate (5 Days Post May 7 Earnings, ~May 14, 2026)

Current Consensus

Estimate Δ (%)

Initial Guidance (May 7 Call)

Current Guidance

Guidance Δ

Consensus vs. Guidance Midpoint

Revenue — 1Q FY2027

$1,457M

$1,457M

0.0%

~$1,455M midpoint (up 11% seq. ±1%)

Unchanged

+0.1%

Non-GAAP EPS — 1Q FY2027

$0.70

$0.70

0.0%

$0.67–$0.71 ($0.69 midpoint)

Unchanged

+1.4% (at top of range)

Non-GAAP EPS — FY2027 (Full Year)

$3.16

$3.21

+1.5%

No explicit FY guidance provided

N/A

N/A

Revenue — FY2027 (Full Year)

$6,163M

$6,175M

+0.2%

No explicit FY guidance provided

N/A

N/A

Non-GAAP Gross Profit — 1Q FY2027

$916M

$916M

0.0%

62.25%–63.25% (62.75% midpoint)

Unchanged

+0.2pp vs. midpoint

Source: Visible Alpha Consensus and Actuals Data. The post-earnings estimate baseline (as of ~May 14, 2026) reflects the consensus as of 5 trading days after the May 7 earnings release. The large jump in 1Q FY2027 EPS consensus from the pre-earnings level (~$0.38 in April 2026) to $0.70 post-earnings reflects the magnitude of the May 7 beat and the upward guidance revision. Estimates have been stable since the initial post-earnings reset, suggesting the Street has fully digested the guidance and is not pricing in incremental upside — the burden of proof is on management to deliver at or above the top of the guided range.

5. Stock Performance

Key Takeaway: MCHP has significantly underperformed SOXX since the May 7 earnings beat, declining ~23% from its post-earnings peak of ~$103 to ~$80 as of August 4, while SOXX is roughly flat over the same period. The underperformance is multiple-driven (NTM EV/EBITDA compressed from ~25x to ~18x over 3 months) rather than estimate-driven, suggesting investor skepticism about the pace of the PCIe Gen 6 ramp, the COO departure, and broader semi sector rotation — not a deterioration in fundamentals.

Benchmark: iShares Semiconductor ETF (SOXX) — appropriate sub-sector benchmark for MCHP as a broadline semiconductor supplier with significant analog, microcontroller, and connectivity exposure. S&P 500 (SPY) included as broad market reference.

Chart: MCHP vs. SOXX vs. S&P 500 — Indexed to 100 at May 7, 2026 (Last Earnings Date) through August 4, 2026. All three series indexed to 100 at the May 7, 2026 close. MCHP (dark navy solid line), SOXX (mid-grey dashed line), SPY (light grey dashed line). Key events marked: June 2 — BofA Conference / Pricing Strategy Announcement; June 9 — Mizuho Conference; July 23 — COO Resignation (8-K).

Period

MCHP Return

SOXX Return

SPY Return

MCHP vs. SOXX

Since May 7 Earnings (to Aug 4)

-20.6%

+10.1%

+5.4%

-30.7pp

Peak (Jun 22) to Aug 4

-21.5% (from $102.71)

-17.3%

+3.4%

-4.2pp

1-Month (to Aug 4)

-7.5%

-2.2%

+5.4%

-5.3pp

Source: Stock Price Data (Yahoo Finance). NTM multiple data from internal stock performance decomposition. MCHP's NTM EV/EBITDA has compressed from ~25x (3 months ago) to ~17.7x currently, while EPS estimates have risen — confirming the underperformance is entirely multiple compression, not estimate cuts. The stock is now trading at a meaningful discount to its recent range, which may represent an attractive entry point if the 1Q FY2027 print confirms the revenue trajectory and PCIe Gen 6 ramp is on track.

6. Peer Commentary & Current-Quarter Read-Throughs

Key Takeaway: Peer commentary from the last 60 days is uniformly constructive for MCHP's June-quarter setup — TXN, STM, ON, and MPWR all reported strong demand, tightening supply, and extending lead times across industrial, automotive, and data center end markets. The read-through is particularly strong for MCHP's industrial and data center segments. The only cautionary note is MPWR's observation that industrial is "lagging a little bit" relative to data center.

Methodology: Only commentary from June 5 – August 5, 2026 earnings calls and conferences discussing then-current or forward quarters is included. Retrospective commentary about already-reported quarters is excluded. Read-through strength is labeled: ★★★ Strong | ★★ Moderate | ★ Weak

Texas Instruments (TXN) — 2Q 2026 Earnings Call, July 22, 2026

Read-Through Strength: ★★★ Strong (Industrial, Automotive, Data Center, Pricing)

STMicroelectronics (STM) — 2Q 2026 Earnings Call, July 23, 2026

Read-Through Strength: ★★★ Strong (Industrial Microcontrollers, Automotive, Data Center, Bookings/Lead Times)

ON Semiconductor (ON) — 2Q 2026 Earnings Call, August 3, 2026

Read-Through Strength: ★★★ Strong (Automotive, Industrial, Data Center, Pricing, Supply Tightening)

Monolithic Power Systems (MPWR) — 2Q 2026 Earnings Call, July 30, 2026

Read-Through Strength: ★★ Moderate (Data Center Strong; Industrial Lagging; Automotive Ramping)

Peer Read-Through Summary Table

Theme

TXN (Jul 22)

STM (Jul 23)

ON (Aug 3)

MPWR (Jul 30)

MCHP Read-Through

Industrial Demand

★★★ +30% YoY

★★★ +34% YoY; ~40% in Q4

★★ +4% YoY; flat Q3

★ Lagging; design-win year

Positive

Automotive Demand

★★★ Mid-teens YoY; broad cycle start

★★★ +16% YoY; better than expected

★★ +7% YoY; Q3 up low single digits

★★ Mid-teens YoY; H2 ramp

Positive

Data Center Demand

★★★ Doubled YoY; +20% QoQ

★★★ +50% YoY; ~90% YoY in Q4

★★★ >2x in 2026; Q3 up high teens

★★★ Floor raised to 130% YoY

Strongly Positive

Supply Tightening / Lead Times

★★ Lead times inching up

★★★ MCU supply tension; tight distribution

★★★ Lead times 27→32 weeks

★★ Channel inventory very low

Positive (validates MCHP lead time expansion thesis)

Pricing Power

★★★ Price increases started; Q3 impact

★★ Selective increases; net neutral

★★★ 2nd round of increases underway

★★ Targeted increases; no gouging

Positive (validates Sep/Dec pricing impact)

Gross Margin Trajectory

★★★ +340bps QoQ; Q3 higher

★★ Sequential improvement; unloading charges persist

★★★ 40–42% Q3; utilization rising

★★ Stable to slightly higher

Positive (utilization-driven expansion consistent with MCHP's underutilization charge reduction)

7. Material News & Developments

Key Takeaway: The most important development since the May 7 earnings call is the COO resignation (July 23) — Richard Simoncic's departure to become CEO of Menlo Microsystems removes a key operational leader just as MCHP is executing its most complex product ramp (PCIe Gen 6) and factory utilization recovery. The pricing strategy pivot (June 1–2) is the second most material development, as it signals a shift in competitive posture that will affect September and December quarters.

8. Insider Transaction Activity

Key Takeaway: All insider activity since the May 7 earnings call consists of open-market sales only — no purchases. The pattern is notable: COO Simoncic sold shares on three separate occasions (May 13, May 22, June 4) totaling 20,000 shares, and subsequently resigned on July 23. Director Chapman sold 13,000 shares across two transactions. While most sales appear discretionary (not flagged as 10b5-1), the clustering of sales in the weeks immediately following the earnings beat — when the stock was near its post-earnings peak — is worth noting. No open-market purchases by any insider.

Name

Title

Transaction Type

Shares

Date

Note

Bunker, Mathew B

Senior VP, Operations

Open Market Sale

10,571

May 13, 2026

Discretionary; direct ownership. Sold ~10 days post-earnings beat.

Simoncic, Richard J

Chief Operating Officer

Open Market Sale

10,000

May 13, 2026

Discretionary; indirect (trust). Subsequently resigned July 23, 2026.

Chapman, Matthew W

Director

Open Market Sale

10,000

May 15, 2026

Discretionary; direct ownership.

Bjornholt, James Eric

Senior VP & CFO

Open Market Sale (10b5-1)

3,667

May 22, 2026

Pre-planned 10b5-1 sale; indirect (trust). Obligation-driven.

Simoncic, Richard J

Chief Operating Officer

Open Market Sale

5,000

May 22, 2026

Discretionary; indirect (trust). Subsequently resigned July 23, 2026.

Chapman, Matthew W

Director

Open Market Sale

3,000

May 28, 2026

Discretionary; direct ownership.

Simoncic, Richard J

Chief Operating Officer

Open Market Sale

5,000

June 4, 2026

Discretionary; indirect (trust). Final sale before resignation announcement (July 23).

Source: SEC Form 4 Filings Database. All transactions are open-market sales (SEC code S / Disposition). The CFO's May 22 sale is the only transaction flagged as a pre-planned 10b5-1 sale; all others appear discretionary. The COO's three sales (20,000 shares total) in the weeks following the earnings beat, followed by his July 23 resignation, are the most notable pattern. No open-market purchases were filed by any MCHP insider during the period.

9. Key Risks & Questions for the Call

Key Risks

Key Questions for the Call

  1. PCIe Gen 6 production ramp: How many units shipped in the June quarter? Which design wins are in initial production? What is the revenue trajectory for the September and December quarters, and is the >$100M/year design win on track for its production ramp?
  2. COO succession: Who is assuming COO responsibilities? Is there an internal candidate or will MCHP conduct an external search? How does the departure affect the factory utilization ramp timeline and the A&D production scale-up?
  3. September-quarter visibility: Management noted at the May 7 call that September-quarter backlog was already higher than June-quarter backlog at the same point in time. Can management provide an update on September-quarter bookings and backlog, and is the sequential growth trajectory continuing?
  4. Underutilization charges: How much did underutilization charges decline in the June quarter from the $46.6M level in March? What is the expected trajectory for September and December quarters, and when do they reach a normalized level?
  5. Pricing implementation: How is customer reception to the September price increases? Are there any customers pushing back or threatening to dual-source? What is the expected gross margin accretion in the December quarter?
  6. Data center revenue breakdown: Can management provide an update on the Data Center Solutions BU revenue trajectory toward the $500M calendar 2026 target? How are the three product lines (storage controllers, memory controllers, PCIe/retimer) tracking individually?
  7. Inventory days trajectory: Where did inventory days end in the June quarter? Is the company on track to reach the 130–150 day target within the next two quarters as guided?
  8. Leverage and capital allocation: Did net debt/EBITDA drop below 3.0x as guided? What is the timeline to the below-2.0x long-term target, and when does share buyback become a priority?